Medizinische Universität Wien-Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onko ( Site 1201)

Vienna 1090

1 studies enrolling now · 1 studies all time

What they study most

Triple-Negative Breast Cancer

Studies at this site

• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) — Recruiting now